Telitacicept Wins China NMPA Nod for Sjögren's Disease
The NMPA approval marks the first regulatory green light globally for a Sjögren's Disease-specific indication, spotligh…
The NMPA approval marks the first regulatory green light globally for a Sjögren's Disease-specific indication, spotligh…
The conditional approval marks a regulatory milestone for dual cytokine inhibition in a kidney disease with limited the…
The device falls outside functional foods and nutraceuticals; operators and editors should note this release is not ali…
The fast-casual chain's Florida push signals growing operator appetite for functional, plant-centric foodservice format…
The TCAR-focused trial evaluates the SwitchGuard NPS paired with the CGuard Prime 80 cm carotid stent platform for stro…
New findings from Psych Congress Elevate underscore neurological symptom management advances, a space adjacent to emerg…
As biologics complexity grows, contract development organizations are investing in end-to-end analytical infrastructure…
A recent executive order places ibogaine among prioritized psychedelic compounds, signaling a potential regulatory path…
As nutraceutical brands increasingly rely on clinical substantiation to defend structure-function claims, site performa…
The underserved patient segment represents an estimated $4 billion annual market opportunity, according to the company.
Type 2 diabetes represents the largest insulin-treated population yet remains among the least served by closed-loop del…
The peer-reviewed findings position continuous EEG monitoring as a clinical decision-making tool in ICU settings — with…